Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-032253
Filing Date
2024-07-18
Accepted
2024-07-18 18:34:08
Documents
1
Period of Report
2024-07-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1721342039.html 4  
1 FORM 4 wk-form4_1721342039.xml 4 7727
  Complete submission text file 0001628280-24-032253.txt   9206
Mailing Address 3122 STERLING CIRCLE SUITE 200 BOULDER CO 80301
Business Address
Rodman David Malcom (Reporting) CIK: 0001672659 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41614 | Film No.: 241125707

Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Issuer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)